Surgical Science Sweden AB (SUSRF)
4.00
0.00 (0.00%)
USD |
OTCM |
Jun 10, 16:00
Surgical Science Sweden Total Liabilities (Quarterly) : 40.81M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 40.81M |
| December 31, 2025 | 45.38M |
| September 30, 2025 | 42.87M |
| June 30, 2025 | 42.58M |
| March 31, 2025 | 41.86M |
| December 31, 2024 | 58.92M |
| September 30, 2024 | 34.85M |
| June 30, 2024 | 34.91M |
| March 31, 2024 | 34.68M |
| December 31, 2023 | 35.47M |
| September 30, 2023 | 36.89M |
| June 30, 2023 | 41.48M |
| March 31, 2023 | 40.16M |
| December 31, 2022 | 39.65M |
| September 30, 2022 | 42.14M |
| June 30, 2022 | 41.95M |
| March 31, 2022 | 44.43M |
| Date | Value |
|---|---|
| December 31, 2021 | 43.41M |
| September 30, 2021 | 45.67M |
| June 30, 2021 | 23.86M |
| March 31, 2021 | 24.02M |
| December 31, 2020 | 5.507M |
| September 30, 2020 | 4.711M |
| June 30, 2020 | 5.488M |
| March 31, 2020 | 5.184M |
| December 31, 2019 | 5.826M |
| September 30, 2019 | 6.288M |
| June 30, 2019 | 2.902M |
| March 31, 2019 | 2.903M |
| December 31, 2018 | 2.287M |
| September 30, 2018 | 1.915M |
| June 30, 2018 | 1.959M |
| March 31, 2018 | 2.199M |
| December 31, 2017 | 1.636M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Elekta AB | 2.141B |
| Senzime AB | 6.982M |
| Redsense Medical AB | 0.4596M |
| Acarix AB | 0.6874M |
| Accuray, Inc. | 405.90M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 504.32M |
| Shareholders Equity (Quarterly) | 463.51M |
| Debt to Equity Ratio | 0.0005 |
| Current Ratio | 4.473 |
| Net Debt Paydown Yield | 0.91% |